Aehr Test Systems Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Aehr Test Systems'in gelirinin artacağı tahmin edilmektedir.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Semiconductor kazanç büyümesi	15.0%
Gelir büyüme oranı	27.3%
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	Low
Son güncelleme	01 Nov 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Kazanç ve Gelir Büyüme Tahminleri

DB:AYB - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
5/31/2027	126	N/A	N/A	N/A	1
5/31/2026	92	N/A	N/A	N/A	1
5/31/2025	71	N/A	N/A	N/A	2
8/30/2024	59	29	0	0	N/A
5/31/2024	66	33	1	2	N/A
2/29/2024	72	15	5	6	N/A
11/30/2023	82	21	6	8	N/A
8/31/2023	75	19	7	8	N/A
5/31/2023	65	15	9	10	N/A
2/28/2023	63	14	3	3	N/A
11/30/2022	61	12	1	2	N/A
8/31/2022	56	9	5	5	N/A
5/31/2022	51	9	1	2	N/A
2/28/2022	38	4	2	2	N/A
11/30/2021	28	1	5	5	N/A
8/31/2021	20	-1	-2	-1	N/A
5/31/2021	17	-2	-3	-3	N/A
2/28/2021	13	-5	-4	-4	N/A
11/30/2020	14	-4	-4	-4	N/A
8/31/2020	19	-2	-1	-1	N/A
5/31/2020	22	-3	-2	-2	N/A
2/29/2020	26	0	-2	-1	N/A
11/30/2019	23	-3	-3	-3	N/A
8/31/2019	22	-4	-5	-5	N/A
5/31/2019	21	-5	-6	-6	N/A
2/28/2019	21	-5	-3	-3	N/A
11/30/2018	25	-2	-3	-2	N/A
8/31/2018	27	-1	1	2	N/A
5/31/2018	30	1	N/A	-1	N/A
2/28/2018	29	0	N/A	-3	N/A
11/30/2017	24	-3	N/A	-5	N/A
8/31/2017	21	-5	N/A	-10	N/A
5/31/2017	19	-6	N/A	-4	N/A
2/28/2017	14	-8	N/A	-6	N/A
11/30/2016	13	-8	N/A	-4	N/A
8/31/2016	13	-8	N/A	-3	N/A
5/31/2016	15	-7	N/A	-6	N/A
2/29/2016	15	-6	N/A	-5	N/A
11/30/2015	15	-4	N/A	-5	N/A
8/31/2015	13	-5	N/A	-4	N/A
5/31/2015	10	-7	N/A	-2	N/A
2/28/2015	14	-5	N/A	-2	N/A
11/30/2014	17	-3	N/A	-2	N/A
8/31/2014	19	0	N/A	-1	N/A
5/31/2014	20	0	N/A	-1	N/A
2/28/2014	18	-1	N/A	0	N/A
11/30/2013	15	-2	N/A	1	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: AYB 'un tahmini kazanç büyümesinin tasarruf oranının ( 1% ) üzerinde olup olmadığını belirlemek için yeterli veri yok.

Kazançlar ve Piyasa: AYB 'un kazançlarının German pazarından daha hızlı büyümesinin öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Yüksek Büyüme Kazançları: AYB şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artıp artmayacağını belirlemek için yeterli veri bulunmuyor.

Gelir ve Pazar: AYB şirketinin gelirinin (yıllık 27.3% ) German pazarından (yıllık 5.6% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: AYB şirketinin gelirinin (yıllık 27.3% ) yıllık 20% dan daha hızlı büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: AYB 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Aehr Test Systems Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Aehr Test Systems, Inc. Reaffirms Earnings Guidance for the Fiscal Year Ending May 30, 2025

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024

Aehr Test Systems Reiterates Earnings Guidance for the Fiscal Year Ending May 31, 2024

Aehr Test Systems Provides Earnings Guidance for the Year 2024

Aehr Test Systems Reiterates Revenue Guidance for the Fiscal Year Ending May 31, 2023

Recent updates

Investor sentiment deteriorates as stock falls 21%

Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $40 million.

First quarter 2025 earnings released: EPS: US$0.023 (vs US$0.16 in 1Q 2024)

Aehr Test Systems, Inc. Reaffirms Earnings Guidance for the Fiscal Year Ending May 30, 2025

Aehr Test Systems, Inc. to Report Q1, 2025 Results on Oct 10, 2024

Aehr Test Systems, Inc., Annual General Meeting, Oct 21, 2024

Investor sentiment improves as stock rises 15%

Investor sentiment deteriorates as stock falls 21%

Independent Director recently sold €172k worth of stock

Aehr Test Systems (NasdaqCM:AEHR) agreed to acquire Incal Technology, Inc for $23.1.

Investor sentiment improves as stock rises 39%

Now 33% overvalued after recent price rise

Aehr Test Systems to Report Q4, 2024 Results on Jul 16, 2024

Now 20% overvalued

Now 21% overvalued

Investor sentiment deteriorates as stock falls 15%

Investor sentiment improves as stock rises 18%

Insufficient new directors

Now 27% overvalued

Now 22% overvalued

New major risk - Revenue and earnings growth

Now 25% overvalued

Third quarter 2024 earnings released: US$0.051 loss per share (vs US$0.15 profit in 3Q 2023)

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024

Investor sentiment deteriorates as stock falls 16%

Aehr Test Systems to Report Q3, 2024 Results on Apr 09, 2024

Investor sentiment deteriorates as stock falls 16%

Investor sentiment improves as stock rises 17%

New minor risk - Insider selling

President recently sold €78k worth of stock

Second quarter 2024 earnings released: EPS: US$0.21 (vs US$0.14 in 2Q 2023)

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024

Investor sentiment deteriorates as stock falls 16%

Aehr Test Systems Announces Resignation of Rhea J. Posedel from Corporate Governance and Nominating Committee

Investor sentiment deteriorates as stock falls 18%

First quarter 2024 earnings released: EPS: US$0.16 (vs US$0.022 in 1Q 2023)

Aehr Test Systems Reiterates Earnings Guidance for the Fiscal Year Ending May 31, 2024

Aehr Test Systems to Report Q1, 2024 Results on Oct 05, 2023

Aehr Test Systems, Annual General Meeting, Oct 23, 2023

Full year 2023 earnings released: EPS: US$0.52 (vs US$0.36 in FY 2022)

Investor sentiment deteriorates as stock falls 17%

President recently sold €5.7m worth of stock

Full year 2023 earnings released: EPS: US$0.52 (vs US$0.36 in FY 2022)

Aehr Test Systems Provides Earnings Guidance for the Year 2024

Aehr Test Systems to Report Q4, 2023 Results on Jul 13, 2023

Aehr Test Systems Appoints Chris Siu, as Chief Financial Officer Effective June 1, 2023

Investor sentiment improves as stock rises 19%

Investor sentiment deteriorates as stock falls 21%

Independent Director recently sold €775k worth of stock

Investor sentiment deteriorates as stock falls 26%

Third quarter 2023 earnings released: EPS: US$0.15 (vs US$0.083 in 3Q 2022)

Investor sentiment improves as stock rises 33%

Investor sentiment improves as stock rises 20%

Insider recently sold €1.2m worth of stock

Aehr Test Systems Announces Board Changes

Investor sentiment improves as stock rises 27%

Independent Director recently sold €381k worth of stock

Investor sentiment improved over the past week

Aehr Test Systems Reiterates Revenue Guidance for the Fiscal Year Ending May 31, 2023

Second quarter 2023 earnings released: EPS: US$0.14 (vs US$0.027 in 2Q 2022)

Aehr Test Systems to Report Q2, 2023 Results on Jan 05, 2023

President recently sold €1.7m worth of stock

Investor sentiment improved over the past week

Vice President of Engineering recently sold €463k worth of stock

Investor sentiment improved over the past week

First quarter 2023 earnings released: EPS: US$0.022 (vs US$0.029 in 1Q 2022)

Aehr Test Systems Provides Revenue Guidance for the Fiscal Year Ending May 31, 2023

Investor sentiment deteriorated over the past week

Aehr Test Systems, Annual General Meeting, Oct 18, 2022